▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1302 by analyst upside · 2026-08-12
PRLD
Prelude Therapeutics Incorporated
Healthcare · Market Cap $424M · P/E 0x
ANALYST PRICE TARGET
+50.4%
implied upside to consensus target
Current Price $5.32
Consensus Target $8.0
Bull Target $10.0
Bear Target $6.0
Analysts Covering 3
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
2
Hold
0
Sell
0
52-Week Low $0.75
52-Week High $5.85
YTD Return +94.9%
FUNDAMENTALS
Market Cap $424M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.00
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $17M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.75
52-Week High $5.85
Current Price $5.32
Bear Target $6.0
Bull Target $10.0
● Now $5.32 ● Target $8.0
TRADING DATA
Avg Volume 412K
YTD Return +94.9%
Analyst Count 3
Consensus Buy
Upside to Target +50.4%
Last Updated 2026-08-12

ANALYST SUMMARY

Prelude Therapeutics Incorporated (PRLD) is currently trading at $5.32 with a Wall Street consensus price target of $8.0, implying potential upside of 50.4% over the next 12 months. 3 analysts currently cover PRLD, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $10.0, while the most cautious has a target of $6.0.

PRLD operates in the Healthcare sector with a market capitalisation of $424M. The stock is up 94.9% year-to-date and is currently trading near the upper end of its 52-week range of $0.75 – $5.85.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

AUNA +30.8%
Auna SA
$395M · P/E 19.8x · Buy
CYH +11.9%
Community Health Systems, Inc.
$400M · P/E 1.5x · Hold
GMRS +62.8%
GMR Solutions Inc.
$643M · P/E 6.2x · Buy
KMDA +83.4%
Kamada Ltd.
$409M · P/E 20.3x · Buy
TCMD +58.4%
Tactile Systems Technology, Inc.
$547M · P/E 27.8x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for PRLD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

D. Boral Capital ● Initiated
Buy 2026-05-04 32% win rate (25 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-04-27 31% win rate (48 calls)
Citizens - Reiterated
Market Outperform → Market Outperform 2026-03-11 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-09-23 31% win rate (48 calls)
JMP Securities - Reiterated
Market Outperform → Market Outperform 2025-08-18 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-05-05 31% win rate (48 calls)
JMP Securities reit
Market Outperform → Market Outperform 2025-04-29 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-04-08 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
53
out of 100
Coverage depth
11/30
Consensus clarity
15/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →